Last reviewed · How we verify
NCT07123766
Clinical Investigation for the PoliaValve Aortic Heart Valve- India
NA trial testing PoliaValve (Aortic) in AORTIC VALVE DISEASES in 50 participants. Not yet recruiting.
30 December 2027
Quick facts
| Lead sponsor | Suzhou Hearthill Medical Technology Co.,LTD |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 15 November 2025 |
| Primary completion | 30 December 2027 |
| Estimated completion | 30 December 2027 |
Drugs / interventions tested
- PoliaValve (Aortic)
Conditions studied
- AORTIC VALVE DISEASES — all drugs for AORTIC VALVE DISEASES →
- Aortic Valve Stenosis — all drugs for Aortic Valve Stenosis →
- Aortic Valve Regurgitation — all drugs for Aortic Valve Regurgitation →
Sponsor
Suzhou Hearthill Medical Technology Co.,LTD
Who can join
45 and older, any sex, with AORTIC VALVE DISEASES or Aortic Valve Stenosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to conduct a clinical investigation of the HeartHill PoliaValve Aortic Valve to collect evidence on the device's safety and performance.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07123766
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of PoliaValve (Aortic)
Trials testing the same drug.
- NCT06518681 — Evaluating the Safety and Efficacy of Prosthetic Polymer Heart Valves for the Treatment of Aortic Valve Disease · NA · enrolling by invitation
Other recruiting trials for AORTIC VALVE DISEASES
Currently open trials in the same condition.
- NCT06818084 — TRanscAtheter TreatMent of PurE Aortic Regurgitation With VitaFlow Liberty System · Phase 4 · recruiting
- NCT06830499 — Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From China · recruiting
- NCT07476703 — Expanded Studies on the SCAPIS Stockholm Reexamination Cohort · recruiting
- NCT04258488 — Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replac · Phase 4 · recruiting
Other Suzhou Hearthill Medical Technology Co.,LTD trials
Trials by the same sponsor.
- NCT06518681 — Evaluating the Safety and Efficacy of Prosthetic Polymer Heart Valves for the Treatment of Aortic Valve Disease · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07123766 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Suzhou Hearthill Medical Technology Co.,LTD
- Last refreshed: 14 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07123766.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing